Hence, Piezo1 promotes ovarian-cancer growth and dissemination via a mechanical–Hippo/YAP–EMT pathway, and its inhibition or blockade represents a promising anti-metastatic strategy (73). Here, PIEZO1 is linked to ovarian carcinoma.